Abbott Wins European Approval for Latest MitraClip Heart Valve Device

Abbott Laboratories (NYSE:ABT) has scored a fresh victory across the Atlantic Ocean. The company announced Monday that it has been granted a CE Mark for its MitraClip G4, the latest version of its popular heart valve replacement device, which means it is approved for use in the countries of the European Union.